Arnaud L. Fauconnier

Prof. Dr. Arnaud L. Fauconnier

Université Paris-Saclay, UVSQ, Unité de recherche 7285 « Risques cliniques et sécurité en santé des femmes et en santé périnatale (RISCQ), 78180 Montigny-le-Bretonneux. Centre Hospitalier Intercommunal de Poissy-Saint-Germain-en-Laye, Service de gynecologie & obstétrique, 78303 Poissy CEDEX, France

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2005 in Human Reproduction
Verified
Journal Article
Open access
PDF file
CCC. Chapron
C. Chapron
HBH. Barakat
H. Barakat
FXFritel Xavier
Fritel Xavier
JDJ.-B. Dubuisson
J.-B. Dubuisson
GBG. Bréart
G. Bréart
AFArnaud L. Fauconnier
Arnaud L. Fauconnier
BACKGROUND: To derive a diagnostic model based on symptoms and history as assessed by a standardized questionnaire to predict posterior deep infiltrating endometriosis (DIE) among women with chronic pelvic pain symptoms. METHODS: 134 women scheduled for laparoscopy for chronic pelvic pain symptoms completed a standardized self-administered questionnaire, specifically designed for the study. We compared the symptoms of the women with posterior DIE diagnosed at laparoscopy with those of the women with other disorders, and used multiple logistic regression analysis to select the best combination of symptoms for predicting posterior DIE. Cross-validation was performed with the jackknife method. RESULTS: 51 women (38.1%) were diagnosed with posterior DIE and 83 with other disorders (61.9%). The following variables were independent predictors for posterior DIE: painful defecation during menses, severe dyspareunia (visual analogic scale ≥8), pain other than noncyclic, and previous surgery for endometriosis. The cross-validation procedure leads to a simplified diagnostic model that uses two independent predictors: painful defecation during menses and severe dyspareunia. The sensitivity of this model for diagnosing posterior DIE was 74.5%, its specificity was 68.7%, its positive likelihood ratio was 2.4, and its negative likelihood ratio was 0.4. It correctly classified 70.9% of our sample into a high-risk (with either severe dyspareunia or painful defecation during menses) and a low-risk (neither symptom) group. CONCLUSIONS: Standardized evaluation of painful symptoms is useful for screening women so that they may have adequate exploration and counselling before laparoscopic surgery for pelvic pain symptoms.

29 July 2013 in Human Reproduction
Verified
Journal Article
Open access
PDF file
AFArnaud L. Fauconnier
Arnaud L. Fauconnier
SSStéphanie Staraci
Stéphanie Staraci
CHC. Huchon
C. Huchon
HRHorace Roman
Horace Roman
PPPierre Panel
Pierre Panel
PDPhilippe Descamps
Philippe Descamps
How do fully-comprehensive patient-centred descriptions of the symptoms of endometriosis compare with the physicians’ description of the symptoms? The description of the painful symptoms due to endometriosis is based on numerous distinct parameters. The way these are used to describe symptoms and the way they are interpreted varies significantly between patients and clinicians. The descriptions of severe pelvic pain and dysmenorrhoea and dyspareunia by the clinicians were incomplete compared with those of the patients. Painful symptoms due to endometriosis were found to be of little use to predict the location and severity of the disease. Currently there are few data on the patients’ description of symptoms and no questionnaire is available to derive data from patients. Descriptions of painful symptoms by patients and by physicians were obtained by qualitative, interview-based study and analysed using Colaizzi's method. The patients planned to be operated on for painful endometriosis were volunteers for preoperative interview. They were recruited by purposeful sampling to represent different types of endometriosis [i.e. superficial endometriosis, ovarian endometriosis or deeply infiltrating endometriosis (DIE)], the women were selected so that at least five sites of endometriosis were included in the study. The clinicians were experts in endometriosis management. Forty-one patients were recruited, in four reference centres. Among them, 33 had DIE in various locations, including intestinal endometriosis (n = 12) or bladder endometriosis (n = 5), 14 had ovarian endometriosis (including three without associated DIE) and 5 had only superficial endometriosis. The nine experts were French-speaking gynaecological surgeons practicing in university teaching hospitals (seven), a general hospital (one) or a private centre (one). In total, 47 themes were identified of which 30 were perceived by both patients and clinicians, 12 by patients only and 5 by clinicians only. Themes fall into five general categories: (i) severe pelvic pain and dysmenorrhoea, (ii) dyspareunia, (iii) gastro-intestinal symptoms, (iv) bladder symptoms, (v) other symptoms. Patients’ and clinicians’ descriptions of symptoms were in agreement for general categories, but the clinicians’ comprehensive description was incomplete, in particular concerning the severe pelvic pain and dysmenorrhoea's themes and the dyspareunia theme. Patients did not report any clear-cut distinction between pelvic pain and dysmenorrhoea and expressed a dimension of suffering and impaired quality of life inherent to painful symptoms. Most of the patients in the study had already had treatment for endometriosis, including ongoing hormonal treatment. Furthermore, all but a few patients had documented endometriotic lesions and no specific investigations to eliminate additional causes of functional pelvic pain were done. Finally due to the qualitative design of the study the result must be regarded as inferences. The present study provides a first person viewpoint of the painful experience of endometriosis by the patients in a subjective, phenomenological perspective, and points out the differences of perceptions between the physicians and the patients. The considerable variability in patients’ descriptions suggests several distinct mechanisms are involved in explaining the pain related to endometriosis. The discordance between clinicians and patients might also reflect this kind of problem with the wording of the items. In future, if the goal is to properly understand the pain experienced by women with endometriosis, assessment tools using the words and phrases used in narratives of pain would potentially be very useful. Funded by IPSEN, Boulogne-Billancourt, France. None of the authors has any conflict of interest to declare. Not applicable.

15 January 2014 in Human Reproduction
Verified
Journal Article
Open access
PDF file
ATA. Torre
A. Torre
BPB. Paillusson
B. Paillusson
VFV. Fain
V. Fain
PLP. Labauge
P. Labauge
JPJ. P. Pelage
J. P. Pelage
AFArnaud L. Fauconnier
Arnaud L. Fauconnier
Does uterine artery embolization (UAE) permit fertility in childbearing women who have extensive symptomatic fibroids and are not eligible for surgery? Although UAE was effective in improving bleeding, bulking and pain symptoms, and in sparing the ovarian reserve, no woman in this study delivered successfully after UAE. Although pregnancies have been reported after UAE, the actual fertility rate after this treatment remains uncertain. This prospective cohort study included 66 women who desired a future pregnancy and were treated with UAE for symptomatic fibroids. This cohort of consecutive patients had extensive symptomatic fibroids but were not eligible for abdominal myomectomy because of fibroid recurrence despite previous surgery, because of current risks of surgery, or because of patient refusal. The patients were enrolled in a tertiary referral center for fibroid treatment. All patients had a pre-operative ovarian function assessment and underwent bilateral superselective embolization of both uterine arteries using 500–1200 µm Tris acryl microspheres. Fibroid symptoms including menorrhagia (OR 0.08, 95% CI 0.02–0.27), metrorrhagia (OR 0.05, 95% CI 0.01–0.39), pain (OR 0.08, 95% CI 0.03–0.22) and bulk syndrome (OR 0.02, 95% CI 0.01–0.07) were significantly improved after UAE. According to magnetic resonance imaging, the dominant fibroid volume decreased by 31.8% (95% CI 12.2–51.3%). Ovarian reserve demonstrated no change after embolization. Thereafter the women were prospectively followed, and 31 of them (aged 37.3 ± 3.5 years) were actively trying to conceive. In spite of 33.4 ± 14.5 months of attempts, only 1 in 31 women became pregnant and she finally miscarried (monthly fecundability rate 0.1% 95% CI 0–0.3%). The high rate of associated infertility factors in our population, and the high frequency of previous surgery, could in part explain these poor reproductive outcomes; however, they should not account for the total absence of ongoing pregnancy. Embolization might have had a negative impact on fertility in our population, which may not be related to ovarian function. The low reproductive outcomes reported in the present study suggest that UAE should not be performed routinely in young women of childbearing age with extensive fibroids. Although this finding was established in a population for whom abdominal myomectomy was declined, a possible adverse effect of UAE on fertility potential should be considered for woman of childbearing age scheduled for embolization. No particular funding was obtained for this study and the authors have no conflict of interest.

3 March 2008 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
AFArnaud L. Fauconnier
Arnaud L. Fauconnier
EZElise Zareski
Elise Zareski
JAJoseph Abichedid
Joseph Abichedid
GBGeorges Bader
Georges Bader
BFBruno Falissard
Bruno Falissard
FXFritel Xavier
Fritel Xavier

13 December 2016 in European Radiology
Verified
Journal Article
Closed access
PDF file
ATAntoine Torre
Antoine Torre
AFArnaud L. Fauconnier
Arnaud L. Fauconnier
VKVanessa Kahn
Vanessa Kahn
OLOlivier Limot
Olivier Limot
LBLaurence Bussierres
Laurence Bussierres
JPJean Pierre Pelage
Jean Pierre Pelage

1 January 2009 in Gynécologie Obstétrique & Fertilité
Verified
Journal Article
Closed access
AFArnaud L. Fauconnier
Arnaud L. Fauconnier
FXFritel Xavier
Fritel Xavier
CCC. Chapron
C. Chapron